Millions are addicted to pain meds and illicit drugs.
The FDA granted TTNP priority review for its implant to treat this epidemic.
TTNP has a 6 month slow release abuse proof medication.
Its ProNeura technology is also being advanced for Parkinson's and chronic pain.
TTNP will earn a $50,000,000 milestone plus tiered double digit royalties upon approval on April 30th.
You want to be holding some shares before April.
I'm bullish on TTNP, more so than on ANAD.